Advanced Search

Related News

Home 禄 Business

Otsuka eyes expansion in China

By Leng Cheng | April 3, 2015, Friday | Online Edition

Japan's major pharmaceutical company Otsuka Holdings Co eyes expansion on production and sales of high-end nutritional supplements in China market to meet the country's rising demand.

China Otsuka Pharmaceutical Co, company's Chinese subsidiary, will build new assembly lines to boost the production of fluids packaged in soft bags, and aims to reach the capacity of 670  million units a year, up 3 times from the current, Japan's Nikkei Newspaper reported.

Company's spokesman Hideki Shirai confirmed with Shanghai Daily today that Otsuka plans to increase production for China market. He added that company had invested billion yuan level into the plants and will "carry out further device investment as required".

Otsuka holds three plants in China, including Tianjin, Dalian and Shunde in Guangdong Province, which mainly produce fluids packaged in plastic bottles and soft bags.

The transfusion fluids are widely given to help patients get enough water and nutrients. The yearly output reached around 17.5 billion units in 2012, up nearly 22 percent annually in the past five years, data compiled by China Pharmaceutical Association of Plant Engineering showed.

Otsuka expects the use of Japanese production and inspection systems to be the key selling point as it increases marketing primarily to large hospitals that practice advanced medicine.

"It's our goal in the future, which hasn't decided formally yet, that to increase our staff of sales representatives to 500 people from around 300 at present, and reach 3.1 billion yuan in sales of transfusion fluids in China by 2019." Shirai told Shanghai Daily today.

Business
锘

 

Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.

娌叕缃戝畨澶 31010602000204鍙

Email this to your friend


锘